Select region
Submit

Subscribe to our news feed

Subscribe

A question?

10/18/2024
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

“The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened compared with last year.

10/4/2024
Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Getinge will issue its Q3 Report 2024 on October 18, 2024, at 08:00 a.m. CEST, followed by a conference call at 10.00-11.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

9/23/2024
Getinge partners with MEDITECH on Talis Clinical solutions to enhance anesthesia management

In response to the growing demands on healthcare systems, Getinge’s Talis Clinical, a leader in anesthesia management solutions, has joined the MEDITECH Alliance Program in the US. This strategic partnership is designed to empower anesthesia teams with advanced tools that streamline workflows, enhance patient safety, and improve clinical outcomes.

9/11/2024
Getinge completes the acquisition of Paragonix Technologies

Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc.

9/1/2024
Getinge makes a provision of MBRL 240 related to Brazilian investigation

Getinge makes a provision of MBRL 240, corresponding to approximately MSEK 480, related to the previously announced negotiations with the Brazilian Comptroller General of the Union (CGU) involving violations of the Brazilian Clean Companies Act.

8/22/2024
Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Today, Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company in the United States for an aggregated purchase price, including upfront and earn out payments, estimated to approximately USD 477 million.

Press Contacts

Lars Mattsson

Interim EVP Brand & Communication
Phone: +46 10 335 0043

Caroline Örmgård

Head of Public & Media Relations
Phone: +46 10 335 0041

Newsroom2

Contact us online

Click below to fill in the appropriate form. We will be in touch shortly.

Are you looking for

Getinge Hybrid OR

Image Gallery

Diverse picture format made available for press article purpose 

Man and woman looking a something together

About us

All you need to know about Getinge a one glance

Cardiosave

Urgent Medical Device Correction

Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)

Newsroom

Don't miss anything

Click on the icons and follow us!